Maynard Um
-
-
-
-
-
-
-
ProMIS Neurosciences, Inc. (PMN) Reports In-Line Q3 EPS
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on ProMIS Neurosciences (PMN)
-
-
-
-
-
-
-
ProMIS Neurosciences (PMN) Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease
-
-
-
-
-
397,059 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

